SMT201500095B - Forme cristalline di sale cloridrato di (4A-R, 9A-S)-1-(1hbenzoimidazolo-5-carbonil)-2,3,4,4A,9,9A-esaidro-1H-indeno[2,1-B]piridin-6-carbonitrile e loro uso come inibitore della hsd1 - Google Patents

Forme cristalline di sale cloridrato di (4A-R, 9A-S)-1-(1hbenzoimidazolo-5-carbonil)-2,3,4,4A,9,9A-esaidro-1H-indeno[2,1-B]piridin-6-carbonitrile e loro uso come inibitore della hsd1

Info

Publication number: SMT201500095B
Authority: SM; San Marino
Prior art keywords: hexahydroid; indeno; carbonitrile; pyridin; carbonyl
Prior art date: 2010-11-05

Application number

SM201500095T

Other languages

English (en)

Italian (it)

Inventor

Matthias Eckhardt

Hans-Juergen Martin

Martin Schuehle

Sandra Sick

Bing-Shiou Yang

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-11-05

Filing date

2015-04-16

Publication date

2015-07-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44999935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201500095(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-11-05 Priority claimed from PCT/US2010/055586 external-priority patent/WO2011057054A1/en

2015-04-16 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2015-07-09 Publication of SMT201500095B publication Critical patent/SMT201500095B/xx

Links

-1 1hbenzoimidazole-5-carbonyl Chemical group 0.000 title 1
FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 title 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 title 1
101100451537 Caenorhabditis elegans hsd-1 gene Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

SM201500095T 2010-11-05 2015-04-16 Forme cristalline di sale cloridrato di (4A-R, 9A-S)-1-(1hbenzoimidazolo-5-carbonil)-2,3,4,4A,9,9A-esaidro-1H-indeno[2,1-B]piridin-6-carbonitrile e loro uso come inibitore della hsd1 SMT201500095B (it)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PCT/US2010/055586 WO2011057054A1 (en)	2009-11-06	2010-11-05	Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
US201161484995P	2011-05-11	2011-05-11
PCT/US2011/059331 WO2012061708A1 (en)	2010-11-05	2011-11-04	Crystalline forms of hydrochloride salt of (4a-r,9a-s) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b] pyridine- 6 -carbonitrile and their use as hsd 1 inhibitors

Publications (1)

Publication Number	Publication Date
SMT201500095B true SMT201500095B (it)	2015-07-09

Family

ID=44999935

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201500095T SMT201500095B (it)	2010-11-05	2015-04-16	Forme cristalline di sale cloridrato di (4A-R, 9A-S)-1-(1hbenzoimidazolo-5-carbonil)-2,3,4,4A,9,9A-esaidro-1H-indeno[2,1-B]piridin-6-carbonitrile e loro uso come inibitore della hsd1

Country Status (36)

Country	Link
US (2)	US8686149B2 (es)
EP (1)	EP2635563B1 (es)
JP (1)	JP2013541592A (es)
KR (1)	KR20130119939A (es)
CN (1)	CN103228642B (es)
AP (1)	AP3521A (es)
AR (1)	AR083678A1 (es)
AU (1)	AU2011323164B2 (es)
BR (1)	BR112013011095A2 (es)
CA (1)	CA2816136A1 (es)
CL (1)	CL2013001221A1 (es)
CO (1)	CO6781480A2 (es)
CY (1)	CY1116043T1 (es)
DK (1)	DK2635563T3 (es)
EA (1)	EA022406B1 (es)
EC (2)	ECSP12011788A (es)
ES (1)	ES2533833T3 (es)
GE (1)	GEP20166481B (es)
HR (1)	HRP20150327T1 (es)
IL (1)	IL225647A0 (es)
ME (1)	ME02066B (es)
MX (1)	MX2013005069A (es)
NZ (1)	NZ609281A (es)
PE (1)	PE20140123A1 (es)
PH (1)	PH12013500879A1 (es)
PL (1)	PL2635563T3 (es)
PT (1)	PT2635563E (es)
RS (1)	RS53900B1 (es)
SG (1)	SG189859A1 (es)
SI (1)	SI2635563T1 (es)
SM (1)	SMT201500095B (es)
TN (1)	TN2012000117A1 (es)
TW (1)	TWI537258B (es)
UA (1)	UA110807C2 (es)
UY (1)	UY33701A (es)
WO (1)	WO2012061708A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR069545A1 (es)	2007-11-16	2010-02-03	Boehringer Ingelheim Pharma	Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
JP5711115B2 (ja)	2008-05-13	2015-04-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ベンゾモルファン及び関連骨格のアリサイクリックカルボン酸誘導体、そのような化合物を含有する医薬及びその使用
JP5670440B2 (ja)	2009-06-02	2015-02-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
EP2440537A1 (en)	2009-06-11	2012-04-18	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011159760A1 (en)	2010-06-16	2011-12-22	Vitae Pharmaceuticals, Inc.	Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh)	2010-11-05	2016-06-11	百靈佳殷格翰國際股份有限公司	六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
EP2744783A1 (en)	2011-08-17	2014-06-25	Boehringer Ingelheim International GmbH	Indenopyridine derivatives
BR112014027884A2 (pt) *	2012-05-09	2017-06-27	Boehringer Ingelheim Int	combinações farmacêuticas para tratamento de distúrbios metabólicos
EP3235813A1 (en)	2016-04-19	2017-10-25	Cidqo 2012, S.L.	Aza-tetra-cyclo derivatives
CN111315735B (zh)	2017-09-04	2024-03-08	C4医药公司	二氢苯并咪唑酮
CN113557235B (zh)	2019-03-06	2025-08-08	C4医药公司	用于药物治疗的杂环化合物
CN118005644B (zh) *	2024-01-29	2025-12-16	中国科学院南海海洋研究所	十氢芴型生物碱及其制备方法和在制备抗菌药物中应用

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL127995C (es)	1963-12-20		Geigy Ag J R
US3341538A (en)	1965-06-18	1967-09-12	Geigy Chem Corp	Certain 2, 6-methano-3-benzazocines
DE1785124A1 (de)	1968-08-13	1971-11-11	Prym Werke William	Reissverschluss
DE2108954A1 (en)	1971-02-25	1972-09-07	Boehringer Sohn Ingelheim	2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents
GB1304175A (es)	1969-03-31	1973-01-24
DE2105743C3 (de)	1971-02-08	1979-11-29	Boehringer Sohn Ingelheim	2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
US3681349A (en)	1970-03-05	1972-08-01	Morton Norwich Products Inc	1-(substituted benzyl) tetrahydro-2-(1h) pyrimidones
US3657257A (en)	1970-08-31	1972-04-18	Robins Co Inc A H	3-aryl-8-carbamoyl nortropanes
DE2229695A1 (de)	1972-06-19	1974-01-31	Boehringer Sohn Ingelheim	2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2338369A1 (de)	1973-07-26	1975-02-13	Schering Ag	Mikrobiologische hydroxylierung von 2,6-methano-3-benzazocinen
SU511005A3 (ru)	1973-10-27	1976-04-15	К.Х.Берингер Зон., (Фирма)	Способ получени (метоксиметилфурилметил)6,7-бензоморфанов или морфинанов
US4009171A (en)	1974-02-21	1977-02-22	Sterling Drug Inc.	N-acylated-11-oxygenated-2,6-methano-3-benzazocine intermediates
DE2411382C3 (de)	1974-03-09	1979-09-06	C.H. Boehringer Sohn, 6507 Ingelheim	2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
US4087532A (en)	1974-03-09	1978-05-02	Boehringer Ingelheim Gmbh	Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
DE2437610A1 (de)	1974-08-05	1976-02-26	Boehringer Sohn Ingelheim	Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
US4108857A (en)	1975-08-18	1978-08-22	Sterling Drug Inc.	Imidazolylmethyl methanobenzazocines
DE2828039A1 (de)	1978-06-26	1980-01-10	Boehringer Sohn Ingelheim	2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
GB9510459D0 (en)	1995-05-24	1995-07-19	Zeneca Ltd	Bicyclic amines
GB9517622D0 (en) *	1995-08-29	1995-11-01	Univ Edinburgh	Regulation of intracellular glucocorticoid concentrations
CA2262502C (en)	1996-07-31	2002-11-26	Nikken Chemicals Co., Ltd.	6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
GB9623944D0 (en)	1996-11-15	1997-01-08	Zeneca Ltd	Bicyclic amine derivatives
US6514977B1 (en)	1997-05-22	2003-02-04	G.D. Searle & Company	Substituted pyrazoles as p38 kinase inhibitors
YU54202A (sh)	2000-01-18	2006-01-16	Agouron Pharmaceuticals Inc.	Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
WO2001055063A1 (en)	2000-01-25	2001-08-02	Idemitsu Petrochemical Co., Ltd.	Novel bisadamantane compounds, process for preparing the same, and novel biadamantane derivatives
DE10034623A1 (de)	2000-07-17	2002-01-31	Bayer Ag	Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren
AU2003234621A1 (en)	2002-05-17	2003-12-02	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
US7135575B2 (en) *	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
EP1610789B1 (en)	2003-03-26	2010-07-21	Merck Sharp & Dohme Corp.	Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
EP1615698B1 (en) *	2003-04-11	2010-09-29	High Point Pharmaceuticals, LLC	New amide derivatives and pharmaceutical use thereof
US7700583B2 (en)	2003-04-11	2010-04-20	High Point Pharmaceuticals, Llc	11β-hydroxysteroid dehydrogenase type 1 active compounds
EA011021B1 (ru)	2004-05-07	2008-12-30	Янссен Фармацевтика Н.В.	Производные адамантилпирролидин-2-она в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы
AU2005279209B2 (en)	2004-08-30	2011-03-24	Janssen Pharmaceutica N.V.	Tricyclic lactam derivatives as 11-BETA hydroxysteroid dehydrogenase inhibitors
EP1802623A1 (en)	2004-10-12	2007-07-04	Novo Nordisk A/S	11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
EP1809626A2 (en)	2004-10-13	2007-07-25	Neurogen Corporation	Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor
EP1864971A4 (en)	2005-03-31	2010-02-10	Takeda Pharmaceutical	PROPHYLACTIC / THERAPEUTIC AGENT AGAINST DIABETES
JP2009514818A (ja)	2005-11-01	2009-04-09	ハイポイントファーマシューティカルズ，リミティドライアビリティカンパニー	置換アミドの製薬学的用途
US8053431B2 (en)	2005-11-01	2011-11-08	High Point Pharmaceuticals, Llc	Pharmaceutical use of substituted amides
JP2007140188A (ja)	2005-11-18	2007-06-07	Fujifilm Corp	ポジ型感光性組成物及びそれを用いたパターン形成方法
WO2007076055A2 (en)	2005-12-22	2007-07-05	Entremed, Inc.	Compositions and methods comprising proteinase activated receptor antagonists
WO2007081570A2 (en)	2005-12-30	2007-07-19	Merck & Co., Inc.	Cholesteryl ester transfer protein inhibitors
US20070197530A1 (en)	2006-01-31	2007-08-23	Yun-Long Li	Amido compounds and their use as pharmaceuticals
CN101541747B (zh)	2006-04-21	2012-11-14	伊莱利利公司	作为11-β-羟基甾族化合物脱氢酶1的抑制剂的联苯基酰胺内酰胺衍生物
DK2029529T3 (da)	2006-04-24	2010-09-20	Lilly Co Eli	Substitueret pyrrolidinone som inhibitor af 11-beta-hydroxysteroiddehydrogenase 1
AU2007244861B2 (en)	2006-04-25	2012-03-15	Eli Lilly And Company	Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
TW200811170A (en)	2006-06-27	2008-03-01	Sanofi Aventis	Urea derivatives of tropane, their preparation and their therapeutic application
US8132151B2 (en)	2006-07-18	2012-03-06	Yahoo! Inc.	Action tags
BRPI0717657A2 (pt)	2006-10-19	2013-12-24	Hoffmann La Roche	Compostos, processo para a preparação de um composto, composição farmacêutica que o compreende, usos de compostos, métodos para o tratamento e profilaxia de diabetes, obesidade, distúrbios alimentares, displidemia e hipertensão e profilaxia de diabetes do tipo ii
TW200829171A (en)	2006-11-17	2008-07-16	Nihon Nohyaku Co Ltd	Haloalkyl sulfonanilide derivatives or salts thereof, herbicide using it as effective constituent and use-method thereof
EP1935420A1 (en)	2006-12-21	2008-06-25	Merck Sante	2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
WO2008106128A2 (en)	2007-02-26	2008-09-04	Vitae Pharmaceuticals, Inc.	CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
EA200970841A1 (ru)	2007-03-09	2010-04-30	ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи	Фармацевтическое применение замещенных амидов
AR067673A1 (es)	2007-07-26	2009-10-21	Vitae Pharmaceuticals Inc	Derivados de 1,3 oxazinan - 2 - ona como inhibidores ciclicos de la 11 beta -hidroxiesteroide deshidrogenasa 1. composiciones farmaceuticas.
AR069207A1 (es)	2007-11-07	2010-01-06	Vitae Pharmaceuticals Inc	Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
AR069545A1 (es) *	2007-11-16	2010-02-03	Boehringer Ingelheim Pharma	Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
EP2252598A2 (en)	2008-02-11	2010-11-24	Vitae Pharmaceuticals, Inc.	1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2245014B1 (en) *	2008-02-12	2011-11-02	Boehringer Ingelheim International GmbH	Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2009102460A2 (en)	2008-02-15	2009-08-20	Vitae Pharmaceuticals, Inc.	Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5538356B2 (ja)	2008-03-18	2014-07-02	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
MX2010011935A (es)	2008-05-01	2011-05-19	Vitae Pharmaceuticals Inc	Inhibidores ciclicos de 11 beta-hidroxiesteroide deshidrogenasa 1.
WO2009134387A1 (en)	2008-05-01	2009-11-05	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2324017B1 (en)	2008-07-25	2014-12-31	Boehringer Ingelheim International GmbH	INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
NZ590495A (en)	2008-07-25	2012-10-26	Vitae Pharmaceuticals Inc	Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8057970B2 (en)	2008-09-01	2011-11-15	D2S, Inc.	Method and system for forming circular patterns on a surface
UA109255C2 (ru)	2009-04-30	2015-08-10	Берінгер Інгельхайм Інтернешнл Гмбх	Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
TWI531571B (zh) *	2009-11-06	2016-05-01	維它藥物公司	六氫茚并吡啶及八氫苯并喹啉之芳基－及雜芳基羰基衍生物
TWI537258B (zh)	2010-11-05	2016-06-11	百靈佳殷格翰國際股份有限公司	六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物

2011
- 2011-10-18 TW TW100137675A patent/TWI537258B/zh not_active IP Right Cessation
- 2011-11-01 AR ARP110104053A patent/AR083678A1/es unknown
- 2011-11-01 UY UY0001033701A patent/UY33701A/es not_active Application Discontinuation
- 2011-11-04 AP AP2013006902A patent/AP3521A/xx active
- 2011-11-04 PL PL11785232T patent/PL2635563T3/pl unknown
- 2011-11-04 ES ES11785232.7T patent/ES2533833T3/es active Active
- 2011-11-04 EA EA201390643A patent/EA022406B1/ru not_active IP Right Cessation
- 2011-11-04 PH PH1/2013/500879A patent/PH12013500879A1/en unknown
- 2011-11-04 US US13/289,418 patent/US8686149B2/en active Active
- 2011-11-04 GE GEAP201113105A patent/GEP20166481B/en unknown
- 2011-11-04 SI SI201130449T patent/SI2635563T1/sl unknown
- 2011-11-04 RS RS20150205A patent/RS53900B1/sr unknown
- 2011-11-04 PT PT117852327T patent/PT2635563E/pt unknown
- 2011-11-04 PE PE2013000949A patent/PE20140123A1/es not_active Application Discontinuation
- 2011-11-04 NZ NZ609281A patent/NZ609281A/en not_active IP Right Cessation
- 2011-11-04 DK DK11785232.7T patent/DK2635563T3/en active
- 2011-11-04 CA CA2816136A patent/CA2816136A1/en not_active Abandoned
- 2011-11-04 SG SG2013026430A patent/SG189859A1/en unknown
- 2011-11-04 WO PCT/US2011/059331 patent/WO2012061708A1/en not_active Ceased
- 2011-11-04 UA UAA201307042A patent/UA110807C2/uk unknown
- 2011-11-04 EP EP11785232.7A patent/EP2635563B1/en active Active
- 2011-11-04 CN CN201180053044.5A patent/CN103228642B/zh not_active Expired - Fee Related
- 2011-11-04 JP JP2013537864A patent/JP2013541592A/ja active Pending
- 2011-11-04 MX MX2013005069A patent/MX2013005069A/es unknown
- 2011-11-04 BR BR112013011095A patent/BR112013011095A2/pt not_active IP Right Cessation
- 2011-11-04 AU AU2011323164A patent/AU2011323164B2/en not_active Ceased
- 2011-11-04 ME MEP-2015-42A patent/ME02066B/me unknown
- 2011-11-04 HR HRP20150327TT patent/HRP20150327T1/hr unknown
- 2011-11-04 KR KR1020137014295A patent/KR20130119939A/ko not_active Withdrawn
2012
- 2012-03-16 TN TNP2012000117A patent/TN2012000117A1/en unknown
- 2012-04-05 EC ECSP12011788 patent/ECSP12011788A/es unknown
2013
- 2013-04-09 IL IL225647A patent/IL225647A0/en unknown
- 2013-05-03 CL CL2013001221A patent/CL2013001221A1/es unknown
- 2013-05-30 CO CO13132839A patent/CO6781480A2/es active IP Right Grant
- 2013-06-05 EC ECSP13012664 patent/ECSP13012664A/es unknown
2014
- 2014-02-26 US US14/190,899 patent/US9120769B2/en active Active
2015
- 2015-02-25 CY CY20151100195T patent/CY1116043T1/el unknown
- 2015-04-16 SM SM201500095T patent/SMT201500095B/xx unknown

Also Published As

Publication number	Publication date
CO6781480A2 (es)	2013-10-31
SI2635563T1 (sl)	2015-04-30
UA110807C2 (uk)	2016-02-25
DK2635563T3 (en)	2015-02-02
EP2635563A1 (en)	2013-09-11
CA2816136A1 (en)	2012-05-10
EA022406B1 (ru)	2015-12-30
KR20130119939A (ko)	2013-11-01
AP2013006902A0 (en)	2013-06-30
TN2012000117A1 (en)	2013-09-19
CL2013001221A1 (es)	2013-11-08
AU2011323164B2 (en)	2015-07-23
AP3521A (en)	2016-01-11
PH12013500879A1 (en)	2013-07-01
AU2011323164A1 (en)	2013-05-02
WO2012061708A1 (en)	2012-05-10
PT2635563E (pt)	2015-04-13
US9120769B2 (en)	2015-09-01
IL225647A0 (en)	2013-06-27
US20140249174A1 (en)	2014-09-04
CN103228642A (zh)	2013-07-31
AR083678A1 (es)	2013-03-13
JP2013541592A (ja)	2013-11-14
EA201390643A1 (ru)	2013-11-29
HK1184144A1 (en)	2014-01-17
US20120157488A1 (en)	2012-06-21
TWI537258B (zh)	2016-06-11
MX2013005069A (es)	2013-08-29
ES2533833T3 (es)	2015-04-15
PE20140123A1 (es)	2014-03-02
SG189859A1 (en)	2013-06-28
GEP20166481B (en)	2016-05-25
NZ609281A (en)	2015-02-27
RS53900B1 (sr)	2015-08-31
EP2635563B1 (en)	2015-01-14
TW201242960A (en)	2012-11-01
HRP20150327T1 (hr)	2015-04-24
UY33701A (es)	2012-05-31
ECSP12011788A (es)	2012-10-30
ECSP13012664A (es)	2013-08-30
PL2635563T3 (pl)	2015-06-30
CY1116043T1 (el)	2017-01-25
BR112013011095A2 (pt)	2016-08-02
ME02066B (me)	2015-05-20
CN103228642B (zh)	2015-02-18
US8686149B2 (en)	2014-04-01

Publication	Publication Date	Title
SMT201500095B (it)	2015-07-09	Forme cristalline di sale cloridrato di (4A-R, 9A-S)-1-(1hbenzoimidazolo-5-carbonil)-2,3,4,4A,9,9A-esaidro-1H-indeno[2,1-B]piridin-6-carbonitrile e loro uso come inibitore della hsd1
BRPI0915231A2 (pt)	2018-06-12	compostos inibidores de quinase e métodos de uso
SMT201500213B (it)	2015-10-30	Alcune triazolopirazine, loro composizioni e metodi d'uso
BRPI0908268A2 (pt)	2018-10-30	compostos do inibidor de raf e seus métodos de uso
SMT201500206B (it)	2015-10-30	Composti spiro-ossindolici e loro uso come agenti terapeutici
SMT201400142B (it)	2014-11-10	Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms
BRPI0920263A2 (pt)	2016-07-12	composto, uso do composto, composição, e, método
SMT201500210B (it)	2015-10-30	Composizioni applicazioni di gel rimovibili per unghie e metodi per il loro uso
BRPI0815979A2 (pt)	2017-06-13	compostos e composições com inibidores de quinase, bem como uso dos mesmos
BRPI0920145A2 (pt)	2017-06-06	compostos de tioamida, método de produção e método de uso dos mesmos
BRPI0911688A2 (pt)	2015-07-28	"compostos de pirimidina, composições e métodos de uso"
BRPI0818003A2 (pt)	2019-09-24	inibidores de csf-1r, composições e métodos de uso
SMT201500218B (it)	2015-10-30	Composti aril-fenil-solfonammido-cicloalchile e loro uso
HUE026568T2 (hu)	2016-06-28	Pirrolokinolin-származékok alkalmazása klinikailag látens mikroorganizmusok elpusztítására
ME03065B (me)	2019-01-20	1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
PL2325181T3 (pl)	2017-09-29	Inhibitor STAT3 zawierający jako składnik aktywny pochodną chinolinokarboksyamidu
PT2585437E (pt)	2014-04-29	Compostos de tioacetato, composições e métodos de uso
BRPI0911332A2 (pt)	2019-09-24	composições e uso de inibidores de epas1
BRPI0812159A2 (pt)	2017-05-02	inibidores de csf-1r, composições e métodos de uso
BRPI0916769A2 (pt)	2017-09-26	derivados de benzilbenzeno deuterados e métodos de uso
BRPI0920183A2 (pt)	2018-05-22	derivados de fenetilamida e seus analogos heterociclicos
BR112013006016A2 (pt)	2016-06-07	compostos de azabenzotiazol, composições e métodos de uso
CO6950501A2 (es)	2014-05-20	Compuestos de 1,2,5-oxadiazol sustituido y su uso herbicidas iii
BR112012031981A2 (pt)	2015-09-15	composição aquosa de ingrediente ativo, processo, uso, método para controlar fungos fitopatogênicos e semente
BRPI0913833A2 (pt)	2015-10-20	uso de corantes ácidos